High prevalence of low bone mineral density in patients with Inflammatory Bowel Disease in the setting of a peripheral Dutch hospital

Background and aims: Osteopenia and osteoporosis are frequently encountered in patients with Inflammatory Bowel Disease (IBD). Our aims were to evaluate the actual practice of screening for low bone mineral density (BMD) by dual energy X-ray absorptiometry (DEXA), to determine the prevalence of low BMD and to investigate the risk factors associated with a low BMD in the IBD population of a regional Dutch hospital. Methods: A retrospective chart review was performed in 474 patients (259 with ulcerative colitis, 210 with Crohn's disease and 5 with indeterminate colitis). DEXA results and potenti... Mehr ...

Verfasser: Van Schaik, Fiona D.M.
Verhagen, Marc A.M.T.
Siersema, Peter D.
Oldenburg, Bas
Dokumenttyp: TEXT
Erscheinungsdatum: 2008
Verlag/Hrsg.: Oxford University Press
Schlagwörter: Regular Papers
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28991877
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://ecco-jcc.oxfordjournals.org/cgi/content/short/2/3/208

Background and aims: Osteopenia and osteoporosis are frequently encountered in patients with Inflammatory Bowel Disease (IBD). Our aims were to evaluate the actual practice of screening for low bone mineral density (BMD) by dual energy X-ray absorptiometry (DEXA), to determine the prevalence of low BMD and to investigate the risk factors associated with a low BMD in the IBD population of a regional Dutch hospital. Methods: A retrospective chart review was performed in 474 patients (259 with ulcerative colitis, 210 with Crohn's disease and 5 with indeterminate colitis). DEXA results and potential predictive factors of low BMD were documented. Predictive factors of low BMD were assessed by logistic regression. Results: DEXA was performed in 168 IBD patients (35.4%). A low BMD ( T -score < − 1) was present in 64.3%. Osteoporosis ( T -score < − 2.5) was found in 23.8%. Low BMI, older age at the moment of diagnosis and male gender were found to be predictive factors of low BMD. For patients with osteoporosis, disease duration was an additional predictive factor. After subgroup analysis predictive factors were found to be the same in patients with Crohn's disease. Conclusions: The prevalence of osteopenia and osteoporosis in IBD patients in a regional centre is as high as the prevalence rates reported from tertiary referral centres. A low BMI, an older age at the moment of diagnosis and male gender were predictive factors of low BMD. Prediction of osteoporosis and osteopenia using risk factors identified in this and previous studies is presently not feasible.